Ketamine for depression in veterans with Parkinson's
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests if ketamine can help treat depression in veterans with Parkinson's disease. It involves several in-person and remote visits, and you will need to avoid certain medications and cannabis for a short time before and during some visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a U.S. military veteran.
- You are between 40 and 80 years old.
- You have been diagnosed with Parkinson's disease for at least 6 months.
- You have tried at least one antidepressant medication that did not help enough.
- You have moderate or greater symptoms of depression (feeling down most days).
- Your medications have been stable for at least 2 months, and you are willing to keep them the same during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain imaging (PET scans) to understand depression in people with Parkinson's disease. It may also test a depression treatment called ketamine, but the main goal is to see how the brain changes with depression.
This study combines behavioral activation therapy (a type of counseling that helps you re-engage in positive activities) with ketamine infusions to treat depression that hasn't improved with standard antidepressants. The goal is to see if adding this therapy makes ketamine work better and last longer.
This study tests whether ketamine, combined with talk therapy, can help veterans with both chronic low back pain and depression. The goal is to reduce pain and improve mood.
This early-phase study tests whether ketamine can help people with major depression who have trouble feeling pleasure. It also studies how the brain may change in response to stress, to better understand who might respond to treatment.
This study tests whether ketamine can help veterans who have both PTSD and depression after a mild to moderate traumatic brain injury. If you qualify, you would receive ketamine or a placebo, and the researchers will see if it improves your symptoms.
This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.